Enfermedad Tromboembólica Pulmonar Secundaria a Sars-Cov-2: entendiendo su Fisiopatología
Resumen
El nuevo coronavirus SARS-CoV-2 ha representado un problema sanitario mundial sin precedentes ocasionando aproximadamente 3 millones de muertes en la región de la Américas desde el año 2019. La enfermedad producida por este virus, denominada Covid-19 tiene el potencial de presentar manifestaciones clínicas que varían desde cuadros asintomáticos y procesos centrales hasta neumonías graves que evolucionan de manera rápida hacia la insuficiencia respiratoria aguda o la muerte. En la actualidad, el aumento significativo de las tasas de tromboembolismos venosos y arteriales en pacientes con infección confirmada ha despertado gran interés entre los expertos quienes han desarrollado una serie de procesos investigativos que han permitido confirmar la presencia de coagulopatías derivadas de mecanismos relacionados con la instauración de estados proinflamatorios y de hipercoagulabilidad. Lo anterior se ha visto reflejado en un mayor riesgo de complicaciones y muerte siendo la embolia pulmonar la afección más comúnmente reportada por lo que por medio de este documento se busca brindar una explicación actualizada sobre la fisiopatología de la problemática en cuestión con el fin de contribuir, desde el entendimiento del proceso, a la identificación oportuna de los casos y, por ende, a la mejoría de los resultados clínicos de los pacientes.
Descargas
Citas
Poor HD. Pulmonary Thrombosis and Thromboembolism in COVID-19. Vol. 160, Chest. Elsevier Inc.; 2021. p. 1471–80.
Sanidas E, Grassos C, Papadopoulos D, Velliou M, Barbetseas J. Pulmonary Embolism Prophylaxis in Patients With COVID-19: An Emerging Issue. Vol. 30, Heart Lung and Circulation. Elsevier Ltd; 2021. p. 1435–41.
OPS, OMS. COVID-19.Respuesta de la OPS/OMS. Julio del 2022. Informe n.o 80. 2022;
di Micco P, Russo V, Lodigiani C. Venous thromboembolism and its association with COVID-19: Still an open debate. Vol. 56, Medicina (Lithuania). MDPI AG; 2020. p. 1–3.
Colling ME, Kanthi Y. COVID–19-associated coagulopathy: An exploration of mechanisms. Vol. 25, Vascular Medicine (United Kingdom). SAGE Publications Ltd; 2020. p. 471–8.
Lorenzo C, Francesca B, Francesco P, Elena C, Luca S, Paolo S. Acute pulmonary embolism in COVID-19 related hypercoagulability. Journal of Thrombosis and Thrombolysis. 2020 Jul 1;50(1):223–6.
Khismatullin RR, Ponomareva AA, Nagaswami C, Ivaeva RA, Montone KT, Weisel JW, et al. Pathology of lung-specific thrombosis and inflammation in COVID-19. Journal of Thrombosis and Haemostasis. 2021 Dec 1;19(12):3062–72.
Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Vol. 69, Inflammation Research. Springer Science and Business Media Deutschland GmbH; 2020. p. 1181–9.
Akhter MS, Hamali HA, Mobarki AA, Rashid H, Oldenburg J, Biswas A. Sars-cov-2 infection: Modulator of pulmonary embolism paradigm. Vol. 10, Journal of Clinical Medicine. MDPI; 2021. p. 1–20.
Roncon L, Zuin M, Barco S, Valerio L, Zuliani G, Zonzin P, et al. Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis. Vol. 82, European Journal of Internal Medicine. Elsevier B.V.; 2020. p. 29–37.
Franchini M, Marano G, Cruciani M, Mengoli C, Pati I, Masiello F, et al. COVID-19-associated coagulopathy. Vol. 7, Diagnosis. Walter de Gruyter GmbH; 2020. p. 357–63.
Rieder M, Goller I, Jeserich M, Baldus N, Pollmeier L, Wirth L, et al. Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19. Journal of Thrombosis and Thrombolysis. 2020 Oct 1;50(3):558–66.
Mirsadraee S, Gorog DA, Mahon CF, Rawal B, Semple TR, Nicol ED, et al. Prevalence of Thrombotic Complications in ICU-Treated Patients With Coronavirus Disease 2019 Detected With Systematic CT Scanning. Critical Care Medicine. 2021 May 1;49(5):804–15.
Motwani M. Abrupt deterioration and pulmonary embolism in COVID-19: A case report. Clinical Medicine, Journal of the Royal College of Physicians of London. 2020 Jul 1;20(4):E95–6.
Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, et al. Pulmonary Embolism in Patients with COVID-19: Awareness of an Increased Prevalence. Vol. 142, Circulation. Lippincott Williams and Wilkins; 2020. p. 184–6.
Mariano RZ, Ramos M de C, Reis F. COVID-19 and pulmonary embolism: Do not forget the association! Vol. 53, Revista da Sociedade Brasileira de Medicina Tropical. Sociedade Brasileira de Medicina Tropical; 2020. p. 1–2.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020 Mar 28;395(10229):1054–62.
Jayarangaiah A, Kariyanna PT, Chen X, Jayarangaiah A, Kumar A. COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response. Vol. 26, Clinical and Applied Thrombosis/Hemostasis. SAGE Publications Inc.; 2020.
Mouhat B, Besutti M, Bouiller K, Grillet F, Monnin C, Ecarnot F, et al. Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients. European Respiratory Journal. 2020;56(4).
Williams SR, Hsu FC, Keene KL, Chen WM, Dzhivhuho G, Rowles JL, et al. Genetic Drivers of von Willebrand Factor Levels in an Ischemic Stroke Population and Association with Risk for Recurrent Stroke. Stroke. 2017 Jun 1;48(6):1444–50.
Llitjos JF, Leclerc M, Chochois C, Monsallier JM, Ramakers M, Auvray M, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. Journal of Thrombosis and Haemostasis. 2020 Jul 1;18(7):1743–6.
Görlinger K, Dirkmann D, Gandhi A, Simioni P. Covid-19-associated coagulopathy and inflammatory response: What do we know already and what are the knowledge gaps? Anesthesia and Analgesia. 2020;1324–33.
Batah SS, Fabro AT. Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians. Vol. 176, Respiratory Medicine. W.B. Saunders Ltd; 2021.
Habashi NM, Camporota L, Gatto LA, Nieman G. Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications. Vol. 130, Journal of Applied Physiology. American Physiological Society; 2021. p. 877–91.
Badraoui R, Alrashedi MM, El-May MV, Bardakci F. Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19. Vol. 39, Journal of Biomolecular Structure and Dynamics. Taylor and Francis Ltd.; 2021. p. 6842–51.
Poyiadji N, Cormier P, Patel PY, Hadied MO, Bhargava P, Khanna K, et al. Acute pulmonary embolism and COVID-19. Vol. 297, Radiology. Radiological Society of North America Inc.; 2020. p. E335–8.
Sakr Y, Giovini M, Leone M, Pizzilli G, Kortgen A, Bauer M, et al. Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review. Vol. 10, Annals of Intensive Care. Springer Science and Business Media Deutschland GmbH; 2020.
Scudiero F, Silverio A, di Maio M, Russo V, Citro R, Personeni D, et al. Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome. Vol. 198, Thrombosis Research. Elsevier Ltd; 2021. p. 34–9.
Joly BS, Siguret V, Veyradier A. Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19. Vol. 46, Intensive Care Medicine. Springer; 2020. p. 1603–6.
van Nieuwkoop C. COVID-19 associated pulmonary thrombosis. Vol. 191, Thrombosis Research. Elsevier Ltd; 2020. p. 151.
Page EM, Ariëns RAS. Mechanisms of thrombosis and cardiovascular complications in COVID-19. Vol. 200, Thrombosis Research. Elsevier Ltd; 2021. p. 1–8.
Grasselli G, Tonetti T, Protti A, Langer T, Girardis M, Bellani G, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020 Dec 1;8(12):1201–8.
Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Vol. 194, Thrombosis Research. Elsevier Ltd; 2020. p. 101–15.
Obi AT, Barnes GD, Napolitano LM, Henke PK, Wakefield TW. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection. Vol. 9, Journal of Vascular Surgery: Venous and Lymphatic Disorders. Elsevier Inc.; 2021. p. 23–35.
Poggiali E, Bastoni D, Ioannilli E, Vercelli A, Magnacavallo A. Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia? Eur J Case Rep Intern Med. 2020 Apr 8;7(5):1.
lok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020 Jul 1;191:145–7.
Derechos de autor 2023 Adriana Maritza Torres Vega ;Rafael Eduardo Arraut Gámez;Sandra Yulitza García Villamizar;Pamela Lix Suárez Jaramillo;Oscar Mauricio Rodríguez Moreno;Brigeth Solanyi Duarte Mesa;Jahir Andrés Ávila Gelvez;Johan Stiven González Gómez
Esta obra está bajo licencia internacional Creative Commons Reconocimiento 4.0.
.jpg)
